Laryngitis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 11:28:12 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Laryngitis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness of Prednisolone for Treating Acute Laryngitis in Vocal Professionals https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-prednisolone-for-treating-acute-laryngitis-in-vocal-professionals/ Wed, 29 Apr 2026 15:05:33 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-prednisolone-for-treating-acute-laryngitis-in-vocal-professionals/ This clinical trial is focused on studying the treatment of acute laryngitis, a condition that causes inflammation of the voice box, often leading to hoarseness. The study is specifically targeting vocal professionals, such as singers, who are experiencing hoarseness that began during or after flu symptoms and has lasted for less than three weeks. The treatment being tested is an oral medication called Prednisolone, which is a type of corticosteroid. Corticosteroids are medications that help reduce inflammation in the body.

The purpose of the study is to determine how effective oral corticosteroid therapy is compared to a placebo in treating acute laryngitis among vocal professionals. Participants in the study will be given either Prednisolone or a placebo to take orally. The study will monitor the duration of vocal symptoms and any inflammatory changes in the larynx, especially in the vocal cords, using a procedure called laryngoscopy, which allows doctors to look at the back of the throat, including the voice box.

The study will take place over a period of time, with participants being observed for changes in their symptoms and any improvements in their condition. The goal is to gather information that could help improve treatment options for those suffering from acute laryngitis, particularly individuals who rely on their voice for their profession. The study is expected to continue until the end of 2027.

]]>